SCHEMBL13701737

SCHEMBL13701737

CN(Cc1ccccc1)C(=O)c1cccc(C(=O)NC(C)(C)C)c1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.74
▸ MEN1 O00255 2/20 0.74
▸ ALDH1A1 P00352 2/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ HDAC1 Q13547 1/20 0.54
▸ HDAC6 Q9UBN7 1/20 0.54
▸ SIRT2 Q8IXJ6 1/20 0.52
▸ MAPT P10636 1/20 0.51
▸ HPGD P15428 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ TP53 P04637 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ HSD17B1 P14061 1/20 0.49
▸ HSD17B2 P37059 1/20 0.49
▸ ADORA2A P29274 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ MLYCD O95822 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13702372 0.83 KMT2A (0.76) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL13229125 0.82 KMT2A (0.90) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL13701791 0.80 LMNA (0.52) KMT2AMEN1ALDH1A1GAAHTT
SCHEMBL1690506 0.80 KMT2A (0.75) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL13229122 0.80 KMT2A (0.80) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1
SCHEMBL13701748 0.78 HDAC2 (0.68) KMT2AALDH1A1SMN1; SMN2HDAC1HDAC6
SCHEMBL1003665 0.78 KMT2A (0.83) KMT2AMEN1ALDH1A1HDAC1HDAC6
SCHEMBL21249304 0.78 LMNA (0.58) KMT2AALDH1A1SMN1; SMN2HDAC6GAA
SCHEMBL18186542 0.77 KMT2A (0.82) KMT2AMEN1ALDH1A1SMN1; SMN2SIRT2
SCHEMBL15676710 0.77 KMT2A (0.82) KMT2AMEN1ALDH1A1SMN1; SMN2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 — — US disclosed
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors EPHX1, EPHX2, EPX KMT2A 3792/4885MEN1 4409/4885ALDH1A1 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback